Twelve hospitals will use the company's assays to screen vulnerable patients for genes from multi-drug resistant organisms.
The test is the first capable of simultaneously identifying Escherichia coli, Klebsiella pneumoniae and Pseudomonas aeruginosa directly from blood cultures containing Gram-negative rods in less than 90 minutes.
The US Food and Drug Administration has granted 510(K) clearance for AdvanDx's 90-minute Yeast Traffic Light PNA FISH protocol for detecting Candida yeast.
AdvanDx received 510(k) clearance for 90-minute versions of its Escherichia coli/Pseudomonas aeruginosa and EK/P. aeruginosa diagnostic tests.
The new version of the peptide nucleic acid fluorescence in situ hybridization test takes 90 minutes instead of 2.5 hours for conventional tests.
Five researchers are to share this year's Albany Medical Center Prize for their work on the CRISPR/Cas9 gene-editing tool, the AP reports.
Stat News reports on how white supremacists cope with surprising genetic ancestry testing results.
In Genome Research this week: sex-biased gene expression evolution in malaria mosquitos, method to find ancient selective sweeps, and more.
Iceland has nearly eliminated Down syndrome from its population, CBS News reports.